{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:36:41Z","timestamp":1792028201514,"version":"4.4.0"},"reference-count":21,"publisher":"American Diabetes Association","issue":"8","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Most diabetic patients with impaired renal function have a urinary albumin excretion rate in the normal range. In these patients, the etiology of renal impairment is unclear, and it is also unclear whether this nonalbumunuric renal impairment is unique to diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>In this study, we examined the frequency and predictors of nonalbumunuric renal impairment (estimated glomerular filtration rate [eGFR] &amp;lt;60 ml\/min per 1.73 m2) in a nationally representative cohort of 3,893 patients with type 2 diabetes and compared our findings with rates observed in the general population from the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) survey (n = 11,247).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Of the 23.1% of individuals with type 2 diabetes who had eGFR &amp;lt;60 ml\/min per 1.73 m2 (95% CI 21.8\u201324.5%), more than half (55%) had a urinary albumin excretion rate that was persistently in the normal range. This rate of renal impairment was predictably higher than that observed in the general population (adjusted odds ratio 1.3, 95% CI 1.1\u20131.5, P &amp;lt; 0.01) but was solely due to chronic kidney disease associated with albuminuria. In contrast, renal impairment in the absence of albuminuria was less common in those with diabetes than in the general population, independent of sex, ethnicity, and duration of diabetes (0.6, 0.5\u20130.7, P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Nonalbuminuric renal impairment is not more common in those with diabetes. However, its impact may be more significant. New studies are required to address the pathogenesis, prevention, and treatment of nonalbuminuric renal disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc08-2186","type":"journal-article","created":{"date-parts":[[2009,5,26]],"date-time":"2009-05-26T22:18:40Z","timestamp":1243376320000},"page":"1497-1502","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":186,"title":["Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)"],"prefix":"10.2337","volume":"32","author":[{"given":"Merlin C.","family":"Thomas","sequence":"first","affiliation":[{"name":"Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;"},{"name":"Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"MacIsaac","sequence":"additional","affiliation":[{"name":"Endocrine Center, Austin Health and University of Melbourne, Heidelberg West, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Jerums","sequence":"additional","affiliation":[{"name":"Endocrine Center, Austin Health and University of Melbourne, Heidelberg West, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Weekes","sequence":"additional","affiliation":[{"name":"Servier Australia, Hawthorn, Victoria, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Moran","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, The Queen Elizabeth Hospital, Woodville, South Australia, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Atkins","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2009,5,26]]},"reference":[{"key":"2022031302541035000_B1","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2337\/dc08-S012","article-title":"Standards of medical care in diabetes\u20142008","volume":"31","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031302541035000_B2","first-page":"S1","article-title":"Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"32","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2008","journal-title":"Can J Diabetes"},{"key":"2022031302541035000_B3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5694\/j.1326-5377.2006.tb00499.x","article-title":"The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)","volume":"185","author":"Thomas","year":"2006","journal-title":"Med J Aust"},{"key":"2022031302541035000_B4","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/ndt\/gfh248","article-title":"The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit","volume":"19","author":"Thomas","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2022031302541035000_B5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diacare.27.1.195","article-title":"Nonalbuminuric renal insufficiency in type 2 diabetes","volume":"27","author":"MacIsaac","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031302541035000_B6","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.289.24.3273","article-title":"Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus","volume":"289","author":"Kramer","year":"2003","journal-title":"JAMA"},{"key":"2022031302541035000_B7","first-page":"161","article-title":"Albuminuric and non-albuminuric pathways to renal impairment in diabetes","volume":"30","author":"MacIsaac","year":"2005","journal-title":"Minerva Endocrinol"},{"key":"2022031302541035000_B8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5694\/j.1326-5377.2006.tb00556.x","article-title":"The assessment of kidney function by general practitioners in Australian patients with type 2 diabetes (NEFRON-2)","volume":"185","author":"Thomas","year":"2006","journal-title":"Med J Aust"},{"key":"2022031302541035000_B9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0168-8227(02)00025-6","article-title":"The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)\u2014methods and response rates","volume":"57","author":"Dunstan","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031302541035000_B10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2022031302541035000_B11","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s00125-006-0275-7","article-title":"Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C\u2013 and creatine-based methods","volume":"49","author":"MacIsaac","year":"2006","journal-title":"Diabetologia"},{"key":"2022031302541035000_B12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5694\/j.1326-5377.2005.tb06958.x","article-title":"Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement","volume":"183","author":"Mathew","year":"2005","journal-title":"Med J Aust"},{"key":"2022031302541035000_B13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"2022031302541035000_B14","volume-title":"Global Guideline for Type 2 Diabetes.","author":"International Diabetes Federation Clinical Guidelines Task Force","year":"2005"},{"key":"2022031302541035000_B15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.106.685628","article-title":"Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)","volume":"116","author":"Barr","year":"2007","journal-title":"Circulation"},{"key":"2022031302541035000_B16","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2337\/dc06-0248","article-title":"Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients","volume":"29","author":"So","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031302541035000_B17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ncpneph0378","article-title":"Anemia in diabetes: marker or mediator of microvascular disease?","volume":"3","author":"Thomas","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"2022031302541035000_B18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.amjcard.2008.08.035","article-title":"Multimorbidity due to diabetes mellitus and chronic kidney disease and outcomes in chronic heart failure","volume":"103","author":"Ekundayo","year":"2009","journal-title":"Am J Cardiol"},{"key":"2022031302541035000_B19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ahj.2008.02.024","article-title":"Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality","volume":"156","author":"McCullough","year":"2008","journal-title":"Am Heart J"},{"key":"2022031302541035000_B20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1464-5491.2001.00406.x","article-title":"Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus","volume":"18","author":"Thompson","year":"2001","journal-title":"Diabet Med"},{"key":"2022031302541035000_B21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/j.ajkd.2005.12.034","article-title":"Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography","volume":"47","author":"Polkinghorne","year":"2006","journal-title":"Am J Kidney Dis"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/32\/8\/1497\/603876\/zdc00809001497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/32\/8\/1497\/603876\/zdc00809001497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:12:15Z","timestamp":1647141135000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/32\/8\/1497\/38945\/Nonalbuminuric-Renal-Impairment-in-Type-2-Diabetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,26]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2009,5,26]]},"published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc08-2186","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,26]]}}}